Enhancer ID: | E_01_0893 |
Species: | human |
Position : | chr4:122448607-122450607 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Leukemia |
Pubmed ID: | 31431927 |
Enhancer experiment: | Western blot, PCR, gel electrophoresis |
Enhancer experiment description: | Melibiosamine, a novel oligosaccharide, suppresses mitogen-induced IL-2 production via inactivation of NFAT and NF?B in Jurkat cells. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Melibiosamine, a novel oligosaccharide, suppresses mitogen-induced IL-2 production via inactivation of NFAT and NF?B in Jurkat cells. |
TF name : | IL2 |
TF experiment: | Western blot,PCR,???? |
TF experiment description: | Melibiosamine, a novel oligosaccharide, suppresses mitogen-induced IL-2 production via inactivation of NFAT and NF?B in Jurkat cells. |
Enhancer function : | Melibiosamine, a novel oligosaccharide, suppresses mitogen-induced IL-2 production via inactivation of NFAT and NF?B in Jurkat cells. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Melibiosamine, a novel oligosaccharide, suppresses mitogen-induced IL-2 production via inactivation of NFAT and NF?B in Jurkat cells. |
SNP ID: | -- |